Login / Signup

Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis.

Barliz WaissengrinDan MirelmanSharon PellesFelix BuksteinDeborah T BlumenthalIdo WolfRavit Geva
Published in: Therapeutic advances in medical oncology (2021)
The rate of neuropathy was reduced among patients treated with cannabis and oxaliplatin. This reduction was more significant in patients who received cannabis prior to treatment with oxaliplatin, suggesting a protective effect. A large prospective trial is planned.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • clinical trial
  • peritoneal dialysis
  • study protocol
  • randomized controlled trial
  • phase iii
  • phase ii
  • replacement therapy